Carbocisteine
Form: Capsules, Oral Solutions/Syrups
Strength: Cap: 375 mg and 750 mg; Oral Solution: 50 mg/5 mL and 750 mg/5 mL
Reference Brands: Mucodyne, Lisomucil®, Rhinathiol®, Muciclar®, Actithiol®, Mucolex®(US)
Category: Respiratory Disorder
Carbocisteine is a widely used mucolytic agent in Europe, effective in managing respiratory conditions like COPD, bronchitis, and bronchiectasis by thinning mucus and improving airway clearance. Available in 375 mg and 750 mg capsules and syrups (250 mg/5 mL, 750 mg/5 mL), it is marketed under popular brands such as Mucodyne®, Lisomucil®, Rhinathiol®, and Muciclar®. Though not approved in the US, Carbocisteine is in high demand across EU and Asia, making it a strong option for pharma B2B, PCD franchise, and export business. Its proven efficacy in respiratory care ensures consistent demand across seasonal and chronic markets.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Fluticasone furoate + Vilanterol
Strength: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol
Form: Powder For Inhalation(DPI/MDI)
Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)
View Details Get Enquiry
Mometasone + Formoterol
Strength: 100 mcg/5 mcg , 200 mcg/5 mcg
Form: Inhaler(MDI)
Reference Brands: Dulera®(US)
View Details Get Enquiry
Ambroxol Hydrochloride
Strength: Tab: 30 mg, 60 mg; Syrup: 15 mg/5 mL, 30 mg/5 mL; Drops: 7.5 mg/mL, 15 mg/mL
Form: Tablets, Syrup & Oral drops
Reference Brands: Mucosolvan®, Flavamed®, Ambrobeta®, Ambroxol-ratiopharm®(EU)
View Details Get Enquiry
Triprolidine HCl + Pseudoephedrine HCl
Strength: Tab: 2.5 mg/60 mg; Oral Solution: 0.5 mg/mL, 0.625 mg/mL, 0.938 mg/mL, and 1.25 mg/mL
Form: Tablet & Oral solution
Reference Brands: Histex®, Vanahist PD®, M-Hist PD®, PediaClear®, Aprodine®, Zymine®, Allerfrim®, ENDAL®
View Details Get Enquiry